These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6796373)

  • 1. Activation of chemicals to proximal carcinogens.
    Sugimura T; Wakabayashi K; Yamada M; Nagao M; Fujino T
    Dev Toxicol Environ Sci; 1980; 8():205-17. PubMed ID: 6796373
    [No Abstract]   [Full Text] [Related]  

  • 2. Microsomal metabolism of dimethylnitrosamine and the cytochrome P-450 dependency of its activation to a mutagen.
    Czygan P; Greim H; Garro AJ; Hutterer F; Schaffner F; Popper H; Rosenthal O; Cooper DY
    Cancer Res; 1973 Nov; 33(11):2983-6. PubMed ID: 4201248
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolic aspects of the comutagenic action of norharman.
    Sugimura T; Nagao M; Wakabayashi K
    Adv Exp Med Biol; 1981; 136 Pt B():1011-25. PubMed ID: 7046384
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolic alpha-hydroxylation of the tobacco-specific carcinogen, N'-nitrosonornicotine.
    Chen CB; Hecht SS; Hoffmann D
    Cancer Res; 1978 Nov; 38(11 Pt 1):3639-45. PubMed ID: 359127
    [No Abstract]   [Full Text] [Related]  

  • 5. Mutagenicity of primary and secondary carcinogens altered by normal and induced hepatic microsomes.
    Popper H; Czygan P; Greim H; Schaffner F; Garro AJ
    Proc Soc Exp Biol Med; 1973 Feb; 142(2):727-9. PubMed ID: 4631999
    [No Abstract]   [Full Text] [Related]  

  • 6. Metabolism of isomeric N-nitroso-N-methylaminopyridines by rat liver microsomes.
    Eisenbrand G; Heydt G; Preussmann R
    IARC Sci Publ; 1982; (41):509-16. PubMed ID: 6897235
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of appearance of mutagenicity of N-nitrosodiphenylamine with norharman.
    Wakabayashi K; Nagao M; Kawachi T; Sugimura T
    IARC Sci Publ; 1982; (41):695-707. PubMed ID: 7141576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolic activation in genotoxicity assays with mammalian cell cultures.
    Belvedere G
    Boll Chim Farm; 1985 Feb; 124(2):57-68. PubMed ID: 4015867
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of dietary protein deficiency on the ability of isolated hepatic microsomes to alter the mutagenicity of a primary and a secondary carcinogen.
    Czygan P; Greim H; Garro A; Schaffner F; Popper H
    Cancer Res; 1974 Jan; 34(1):119-23. PubMed ID: 4588542
    [No Abstract]   [Full Text] [Related]  

  • 10. Inhibition of target tissue activation of N'-nitrosonornicotine and N-nitrosopyrrolidine by dietary components.
    Chung FL; Juchatz A; Vitarius J; Reiss B; Hecht SS
    IARC Sci Publ; 1984; (57):797-804. PubMed ID: 6533067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interstrain comparison of hepatic and renal microsomal carcinogen metabolism and liver S9-mediated mutagenicity in DA and Lewis rats phenotyped as poor and extensive metabolizers of debrisoquine.
    Hietanen E; Malaveille C; Camus AM; Béréziat JC; Brun G; Castegnaro M; Michelon J; Idle JR; Bartsch H
    Drug Metab Dispos; 1986; 14(1):118-26. PubMed ID: 2868854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the metabolic activation of N-nitrosomorpholine and N'-nitrosonornicotine: effects of deuterium substitution.
    Hecht SS; Young R; Rivenson A; Hoffmann D
    IARC Sci Publ; 1982; (41):499-507. PubMed ID: 7141557
    [No Abstract]   [Full Text] [Related]  

  • 13. Immunochemical study on the role of different types of microsomal cytochrome P-450 in mutagenesis by chemical carcinogens.
    Kawajiri K; Yonekawa H; Harada N; Noshiro M; Omura T; Tagashira Y
    Cancer Res; 1980 May; 40(5):1652-7. PubMed ID: 6768451
    [No Abstract]   [Full Text] [Related]  

  • 14. Reactive metabolites from N-nitrosamines.
    Archer MC; Milligan JR; Skotnicki S; Lu SJ
    Adv Exp Med Biol; 1991; 283():521-4. PubMed ID: 2069023
    [No Abstract]   [Full Text] [Related]  

  • 15. The metabolism of a series of methylalkylnitrosamines.
    Farrelly JG; Stewart ML
    Carcinogenesis; 1982; 3(11):1299-302. PubMed ID: 7151248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro metabolic activation of N,N-dibutylnitrosamine in mutagenesis.
    Suzuki E; Mochizuki M; Wakabayashi Y; Okada M
    Gan; 1983 Feb; 74(1):51-9. PubMed ID: 6341155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of carcinogens by human liver cytochromes P-450.
    Guengerich FP; Shimada T; Iwasaki M; Butler MA; Kadlubar FF
    Basic Life Sci; 1990; 53():381-96. PubMed ID: 2282045
    [No Abstract]   [Full Text] [Related]  

  • 18. Metabolism of 4-nitroquinoline 1-oxide and related compounds.
    Tada M
    Carcinog Compr Surv; 1981; 6():25-45. PubMed ID: 6786744
    [No Abstract]   [Full Text] [Related]  

  • 19. Contributions of two inducible forms of cytochrome P-450 in rat liver microsomes to the metabolic activation of various chemical carcinogens.
    Kawajiri K; Yonekawa H; Gotoh O; Watanabe J; Igarashi S; Tagashira Y
    Cancer Res; 1983 Feb; 43(2):819-23. PubMed ID: 6401224
    [No Abstract]   [Full Text] [Related]  

  • 20. Mutagenesis, carcinogenesis and alkylating properties of nitrosamines and related compounds.
    Lijinsky W
    Prog Clin Biol Res; 1986; 209B():141-8. PubMed ID: 3749074
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.